Αρχική World News News digest – dinosaur bone cancer, YouTube junk food ad ban and...

News digest – dinosaur bone cancer, YouTube junk food ad ban and COVID-19 updates

Doctors diagnose cancer in a dinosaur

The horned dinosaur, originally excavated in 1989, was originally thought to have a leg fracture that hadn’t healed properly. But a team of scientists have since diagnosed the plant-eating Centrosaurus with osteosarcoma, a type of bone cancer. The dinosaur, which lived around 77 million years ago, is thought to be one of the oldest examples of cancer. Scientists say studying the fossilised remains could help to uncover more about the evolutionary origins of disease. Read the full story at Science Mag.

NHS to roll out “COVID-friendly” cancer treatments

The £160 million initiative will pay for drugs that require fewer hospital visits or have fewer side-effects affecting the immune system, both of which can leave patients more susceptible to infection. Since the pandemic began, almost 2,000 people have been given these therapies, which has allowed their treatment to continue rather than being delayed or halted.

Text reminders boost screening uptake

Campaigners are urging the NHS to send text reminders to everyone invited for screening, after the SMS iniative boosted cervical screening participation by around 5% in a recent study by Imperial.  Currently, only 34% of GP practices are able to send text reminders for screening invites. More on this at The Times (£).

Google to block junk food ads for under-18s

The Daily Mail reports on Google’s ‘junk food crackdown’, banning junk food adverts being shown to children in the UK on all its platforms, including YouTube. The announcement comes a week after the UK Government launched a new strategy to tackle obesity, including restrictions on junk food marketing on TV and online. While the move is a step in the right direction, age verification doesn’t always work as well as it should, which is why we’ve called for a 9pm watershed.

Not all cancer patients ‘vulnerable’ to COVID-19

A group of oncologists have argued that not all cancer patients should be considered vulnerable to COVID-19, reports the Pharmaceutical Journal. They’re calling for evidence-based treatment decisions, which will be helped by the data collected on people with cancer’s experience during the pandemic. In similar news, BBC covered new study findings that suggest continuing chemotherapy and immunotherapy may not pose a risk for some cancer patients with COVID-19.

“The NHS must never again be a COVID-only service.”

Experts are urging NHS bosses not to impose the same mass closure of services that were introduced in March if a second wave of COVID-19 hits, reports The Guardian. We’ve blogged before about what needs to happen to get cancer services back on track during the coronavirus pandemic.

And finally…

More than two million people in England, Scotland and Northern Ireland can now leave their home and return to work, as shielding ends. People shielding in Wales have been advised to continue until 16 August. Read more at BBC.

Scarlett Sangster is a writer for PA Media Group

More on this topic

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Mothers Raise Girls Together After Discovering They Were Swapped At Birth

On New Years’ Even in 1998, two baby girls were born at a hospital in a Sicilian fishing port, Mazara del Vallo. The babies were...

Firefighters Band Together To Raise $30k For Breast Cancer Research & Care

Firefighters save lives as part of their job, but this group of firefighters are deemed heroes for more than just their firefighter duties. When they...

Foodie Friday: Butternut Squash Macaroni Casserole

As we move into fall, grocery stores and farmer’s markets are moving beautiful, health-filled butternut squash to their produce sections! When I saw this recipe...

Extra or Missing Chromosomes May Help Cancer Cells Survive Treatment

September 24, 2021, by NCI Staff Most healthy human cells have 23 pairs of chromosomes, 1 through 22, plus X and Y. Many cancer cells,...

A winding journey into the world of children’s and young people’s cancer research

“It seems strange trying to describe my career path, as the words imply that there was some sort of intention or plan as to...

Early Signs of Efficacy of New Targeted Agents and Immunotherapies Reported for Multiple Cancers at ESMO Congress 2021 [ESMO Congress 2021 Press Release]

LUGANO, Switzerland – Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with...